Brief: Galmed To Expand Drug Development Activities To Cancer, Cardiometabolic Diseases

Eocene

19/09/2024 12:27

Sept 19 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED ANNOUNCES AN EXPANSION OF ITS ACTIVITIES TO CANCER
AND
MAJOR CARDIOMETABOLIC DISEASES
    * GALMED PHARMACEUTICALS LTD - TO DEVELOP ARAMCHOL-BASED
DRUG
COMBINATIONS FOR CANCER
    * GALMED PHARMACEUTICALS LTD - TO DEVELOP ARAMCHOL-BASED
DRUG FOR
CARDIAC FIBROSIS
    * GALMED PHARMACEUTICALS LTD - TO RELEASE NEW DATA FROM
STUDIES IN
Q4 2024

Source text for Eikon:  ID:nPn5Kz8Kta 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))